Understanding the mechanisms that drive AT2 cell differentiation in HPS-PF and the optimal method to modulate the p53 pathway to promote epithelial maintenance and repair and prevent fibrotic remodeling will be critical. The gene discussed is TP53; the disease is Hermansky-Pudlak syndrome.